These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 32735534)

  • 1. Onychomycosis: Current Understanding and Strategies for Enhancing Drug Delivery into Human Nail Tissue.
    Aslam R; Hussain T; Yousaf AM; Ghori MU; Khan IU; Rizvi SAA; Shahzad Y
    Curr Drug Res Rev; 2021; 13(1):25-35. PubMed ID: 32735534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.
    Sakamoto M; Sugimoto N; Kawabata H; Yamakawa E; Kodera N; Pillai R; Tatsumi Y
    J Drugs Dermatol; 2014 Nov; 13(11):1388-92. PubMed ID: 25607707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging topical onychomycosis therapies - quo vadis?
    Elkeeb R; Hui X; Murthy N; Maibach HI
    Expert Opin Emerg Drugs; 2014 Dec; 19(4):489-95. PubMed ID: 25401504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical and physical strategies in onychomycosis topical treatment: A review.
    Angelo T; Borgheti-Cardoso LN; Gelfuso GM; Taveira SF; Gratieri T
    Med Mycol; 2017 Jul; 55(5):461-475. PubMed ID: 27703019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis.
    Bhatt V; Pillai R
    J Pharm Sci; 2015 Jul; 104(7):2177-82. PubMed ID: 25940933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transungual delivery of terbinafine by iontophoresis in onychomycotic nails.
    Nair AB; Vaka SR; Murthy SN
    Drug Dev Ind Pharm; 2011 Oct; 37(10):1253-8. PubMed ID: 21457120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancing transungual delivery and spreading of efinaconazole under the nail plate through a unique formulation approach.
    Kircik LH
    J Drugs Dermatol; 2014 Dec; 13(12):1457-61. PubMed ID: 25607788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent progress on the topical therapy of onychomycosis.
    Alley MR; Baker SJ; Beutner KR; Plattner J
    Expert Opin Investig Drugs; 2007 Feb; 16(2):157-67. PubMed ID: 17243936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel nail penetration enhancer containing vesicles "nPEVs" for treatment of onychomycosis.
    Bseiso EA; Nasr M; Sammour OA; Abd El Gawad NA
    Drug Deliv; 2016 Oct; 23(8):2813-2819. PubMed ID: 26447337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment and management strategies of onychomycosis.
    Aggarwal R; Targhotra M; Kumar B; Sahoo PK; Chauhan MK
    J Mycol Med; 2020 Jun; 30(2):100949. PubMed ID: 32234349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Vehicle for Enhanced Drug Delivery Across the Human Nail for the Treatment of Onychomycosis.
    Turner R; Weaver S; Caserta F; Brown MB
    Int J Pharm Compd; 2016; 20(1):71-80. PubMed ID: 27125057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermatopharmacology of ciclopirox nail lacquer topical solution 8% in the treatment of onychomycosis.
    Bohn M; Kraemer KT
    J Am Acad Dermatol; 2000 Oct; 43(4 Suppl):S57-69. PubMed ID: 11051135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective.
    Elsayed MM
    J Control Release; 2015 Feb; 199():132-44. PubMed ID: 25481439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transungual delivery of ketoconazole using novel lacquer formulation.
    Hafeez F; Hui X; Chiang A; Hornby S; Maibach H
    Int J Pharm; 2013 Nov; 456(2):357-61. PubMed ID: 24029171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New antifungal therapies for the treatment of onychomycosis.
    Kumar S; Kimball AB
    Expert Opin Investig Drugs; 2009 Jun; 18(6):727-34. PubMed ID: 19426118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Onychomycosis: Diagnosis and management.
    Singal A; Khanna D
    Indian J Dermatol Venereol Leprol; 2011; 77(6):659-72. PubMed ID: 22016272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ungual and transungual drug delivery.
    Shivakumar HN; Juluri A; Desai BG; Murthy SN
    Drug Dev Ind Pharm; 2012 Aug; 38(8):901-11. PubMed ID: 22149347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and development of a safer non-invasive transungual drug delivery system for topical treatment of onychomycosis.
    Pal P; Thakur RS; Ray S; Mazumder B
    Drug Dev Ind Pharm; 2015; 41(7):1095-9. PubMed ID: 24980914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transungual permeation: current insights.
    Bhuptani RS; Deshpande KM; Patravale VB
    Drug Deliv Transl Res; 2016 Aug; 6(4):426-39. PubMed ID: 26419676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug delivery to the nail: therapeutic options and challenges for onychomycosis.
    Barot BS; Parejiya PB; Patel HK; Mehta DM; Shelat PK
    Crit Rev Ther Drug Carrier Syst; 2014; 31(6):459-94. PubMed ID: 25271773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.